#1 Clinical Trials Search in Europe by CTIN

Our offer Newsroom

Find a treatment: By disease

Search all trials

Find therapies in clinical trials near you – page 14

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Hepatocellular carcinoma

Not recruiting

Registered drugNo placebo

Study on Durvalumab and Tremelimumab for Patients with Advanced Liver Cancer Not Treatable by Surgery

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Durvalumab

Contact Research Centre

Eosinophilic gastritis

Not recruiting

Registered drug

Study on the Safety and Effectiveness of Dupilumab for Adults and Adolescents with Eosinophilic Gastritis and Eosinophilic Duodenitis

Registered drug

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Dupilumab

Contact Research Centre

Endometrial cancer+6

Not recruiting

Registered drugNo placebo

Study on Pembrolizumab, Lenvatinib, and Belzutifan for Patients with Liver, Colon, Pancreatic, Bile Duct, Gallbladder, Endometrial, or Esophageal Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Belzutifan

Contact Research Centre

Pancreatic carcinoma+3

Not recruiting

InvestigationalNo placebo

Study on BI 907828 for Patients with Advanced Biliary Tract, Pancreatic, Lung, or Bladder Cancer

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:(3S,3'S,3A's,10A's)-6-Chloro-3'-(3-Chloro-2-Fluorophenyl)-1'-(Cyclopropylmethyl)-6'-Methyl-2-Oxo-1,2,3',3A',10',10A'-Hexahydro-1'H-Spiro[Indole-3,2'-Pyrrolo[2',3':4,5]Pyrrolo[1,2-B]Indazole]-7'-Carboxylic Acid

Contact Research Centre

Crohn's disease

Not recruiting

Registered drugNo placebo

Study on Managing Moderate Postoperative Recurrence in Crohn's Disease with Infliximab for Patients After Ileocolonic Surgery

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Infliximab

Contact Research Centre

Hepatocellular carcinoma

Not recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of TheraSphere, Durvalumab, and Tremelimumab for Patients with Liver Cancer (Hepatocellular Carcinoma)

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Durvalumab

Contact Research Centre

Hepatocellular carcinoma

Not recruiting

Registered drugNo placebo

Study on Hepatocellular Carcinoma: Evaluating Livmoniplimab and Budigalimab for Patients with Advanced or Metastatic Cancer After First-Line Treatment

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Budigalimab

Contact Research Centre

Portal hypertension

Not recruiting

Investigational

Study on the Effects of BI 685509 for Patients with Liver Cirrhosis and Portal Hypertension After First Decompensation Event

Investigational

France

Participants:18–64 years · 65+ years
Substances:Bi 685509

Contact Research Centre

Biliary neoplasm

Not recruiting

Registered drug

Study of pembrolizumab with gemcitabine and cisplatin as first treatment for patients with advanced or inoperable bile duct cancer

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Cisplatin

Contact Research Centre

Hepatocellular carcinoma

Not recruiting

Registered drugNo placebo

Study on Regorafenib and Pembrolizumab for Patients with Intermediate-Stage Liver Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Acute myocardial infarction+5

Not recruiting

Investigational

Study on the Effects of Zalunfiban for Patients with ST-Elevation Myocardial Infarction (Heart Attack)

Investigational

France

Participants:18–64 years · 65+ years
Substances:Zalunfiban

Contact Research Centre

Hepatic cirrhosis

Not recruiting

Registered drugNo placebo

Study on the Safety of Human Serum Albumin and Enoxaparin in Patients with Decompensated Cirrhosis at High Risk of Poor Outcome

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Enoxaparin Sodium

Contact Research Centre

Explore other searches

Helpful resources

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.